Clinical Trial

Team Lifestyle Immersion Hypertension Control Project

Study acronym: TLIP
Recruiting
View on ClinicalTrials.gov →
Summary
This project is focuses on reducing the risk and progression of hypertension among a population that records high incidence of hypertension and other chronic ailments such as heart disease, diabetes, kidney failure, and obesity, with similar control measures. Several clinical trials over the last five decades have emphasized the importance of supportive lifestyle modification in the control of chronic disease that include a healthy diet, physical activity, quitting tobacco use, reducing alcohol use to the minimum, self-management of the disease, and adequate sleep. Study participants will receive motivation and skill development support in additional to specific nutrition, physical fitness, and self-management counselling from certified experts. This intervention incorporates elements of the American Heart Association prescription for health, Life's Simple 7 (LS7) lifestyle modification, the Dietary Approaches to preventing Hypertension (DASH) eating plan. After receiving these interventions, participants will be contacted at 3-months, 6-months, and 12-months for follow-up. They will complete similar surveys to be compared to determine impact on their hypertension. This intervention is complementary to usual pharmaceutical hypertension management.
Trial Details
NCT Number NCT07201948
Lead Sponsor Meharry Medical College
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions Hypertension
Enrollment 220 participants
Start Date 2025-06-01
Primary Completion 2027-12-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-01